Expression of carbonic anhydrase IX in human pancreatic cancer.
about
Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progressionZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB.Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancerExpression of carbonic anhydrase 9 at the invasion front of gastric cancersZIP4 silencing improves bone loss in pancreatic cancerSulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo.Hypoxia and angiogenesis in pancreatic cancer.Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia.Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers.A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growthNear-Infrared Fluorescence Imaging of Carbonic Anhydrase IX in Athymic Mice Bearing HT-29 Tumor XenograftsTumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer.Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers.Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors.Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.Acid-base transport in pancreatic cancer: molecular mechanisms and clinical potential.Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.Down regulation of CAII is associated with tumor differentiation and poor prognosis in patients with pancreatic cancer.Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts.Roles of Carbonic Anhydrase IX in Development of Pancreatic Cancer.Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma.Modulation of carbonic anhydrase activity and its applications in therapy
P2860
Q28610062-7C89F13A-97E7-4370-8D3A-A324445ABCE7Q33737752-29590797-9267-4923-859A-1E0D5B81C1E3Q33856008-FBFE9926-E463-44A8-8760-ECBC4C3F0045Q35597597-EDE81C47-ADBF-43BE-9B92-9961F29FE5EAQ36413357-D5C8FF28-EB24-4FC2-B199-DA413F08C21BQ36546587-DFD6C289-656F-44CB-8FFD-D43ECF023B56Q36572752-D6ED9FD2-C5C5-4005-B609-695D33CF4A2DQ36640466-71F96970-6E17-42C0-BFDA-0A834A00F146Q36816042-64195644-6575-4833-B557-33F880B852F5Q37236890-D800BF26-F796-4941-8813-6AE032166C74Q37250091-618DAAEB-AC0E-4FB6-BB48-3FF7D1E98473Q37295258-ACE1C060-CD2E-4A2D-90C8-BD752A56EC8CQ37690276-B1A96807-769B-41ED-8A16-19E24BAA04A4Q37710994-3F2D8AC1-AF3D-415E-8400-ABDB99957737Q38154554-67F6A819-EDB1-4F8D-8AB8-A75EF543B194Q38265305-618DAD80-A236-42DE-BE8C-6ED5260D2942Q38734017-DFC3B073-8BDB-4216-A53E-C4AA8B1BA6A8Q39254783-746164BE-64BA-423B-8062-D68400D4467CQ42575789-331390AF-1B63-44E5-9BC0-4956554A03EDQ50531648-F63B67B6-B3AA-4E68-AFF3-5400F6022B24Q55712021-30595A25-563B-4100-8D4B-B9C6F2CC5DC3Q58863293-4AE92AAB-A905-4146-9911-7F2102378FEC
P2860
Expression of carbonic anhydrase IX in human pancreatic cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Expression of carbonic anhydrase IX in human pancreatic cancer.
@en
Expression of carbonic anhydrase IX in human pancreatic cancer.
@nl
type
label
Expression of carbonic anhydrase IX in human pancreatic cancer.
@en
Expression of carbonic anhydrase IX in human pancreatic cancer.
@nl
prefLabel
Expression of carbonic anhydrase IX in human pancreatic cancer.
@en
Expression of carbonic anhydrase IX in human pancreatic cancer.
@nl
P2093
P2860
P1476
Expression of carbonic anhydrase IX in human pancreatic cancer.
@en
P2093
H-U Kasper
M P A Ebert
P Malfertheiner
S Pastorekova
U Lendeckel
Z Tulassay
P2860
P304
P356
10.1046/J.1365-2036.2003.01738.X
P407
P577
2003-10-01T00:00:00Z